3 Biotech
Journal Title
- 3 Biotech
ISSN
- E 2190-5738 | P 2190-572X
Publisher
- Springer International Publishing AG
Listed on(Coverage)
| JCR | 2015-2023 |
|---|---|
| SJR | 2016-2020;2022-2023 |
| CiteScore | 2015-2023 |
| SCIE | 2015-2024 |
| CC | 2019-2024 |
| SCOPUS | 2017-2024 |
| EMBASE | 2016-2024 |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- GERMANY
Aime & Scopes
- 3 Biotech publishes the results of the latest research related to the study and application of biotechnology to: /// Medicine and Biomedical Sciences /// Agriculture /// The Environment The focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech appeals to scientists and engineers in both academia and industry focusing on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment. Articles from a huge variety of biotechnology applications are welcome including: /// Cancer and stem cell research /// Genetic engineering and cloning /// Bioremediation and biodegradation /// Bioinformatics and system biology /// Biomarkers and biosensors /// Biodiversity and biodiscovery /// Biorobotics and biotoxins /// Analytical biotechnology and the human genome 3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance. 3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including: /// Science Citation Index Expanded /// Journal Citation Reports/Science Edition /// Biological Abstracts /// BIOSIS Previews 3 Biotech publishes under the Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a waiting line. This will ensure that all articles in 3 Biotech are immediately available for researchers in relevant indexing and abstracting databases.